182 related articles for article (PubMed ID: 37514038)
1. Enteric-Coated Cysteamine Bitartrate in Cystinosis Patients.
Klank S; van Stein C; Grüneberg M; Ottolenghi C; Rauwolf KK; Grebe J; Reunert J; Harms E; Marquardt T
Pharmaceutics; 2023 Jun; 15(7):. PubMed ID: 37514038
[TBL] [Abstract][Full Text] [Related]
2. A novel sustained-release cysteamine bitartrate formulation for the treatment of cystinosis: Pharmacokinetics and safety in healthy male volunteers.
Berends CL; Pagan L; van Esdonk MJ; Klarenbeek NB; Bergmann KR; Moerland M; van der Wel V; de Visser SJ; Büller H; de Loos F; de Vries WS; Waals H; de Leede LGJ; Burggraaf J; Kamerling IMC
Pharmacol Res Perspect; 2021 Apr; 9(2):e00739. PubMed ID: 33764642
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of enteric-coated cysteamine bitartrate in healthy adults: a pilot study.
Gangoiti JA; Fidler M; Cabrera BL; Schneider JA; Barshop BA; Dohil R
Br J Clin Pharmacol; 2010 Sep; 70(3):376-82. PubMed ID: 20716238
[TBL] [Abstract][Full Text] [Related]
4. A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis.
van Stein C; Klank S; Grüneberg M; Ottolenghi C; Grebe J; Reunert J; Harms E; Marquardt T
Orphanet J Rare Dis; 2021 Sep; 16(1):387. PubMed ID: 34521447
[TBL] [Abstract][Full Text] [Related]
5. Halitosis in cystinosis patients after administration of immediate-release cysteamine bitartrate compared to delayed-release cysteamine bitartrate.
Besouw M; Tangerman A; Cornelissen E; Rioux P; Levtchenko E
Mol Genet Metab; 2012 Sep; 107(1-2):234-6. PubMed ID: 22832073
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment of cystinosis in children with twice-daily cysteamine.
Dohil R; Gangoiti JA; Cabrera BL; Fidler M; Schneider JA; Barshop BA
J Pediatr; 2010 May; 156(5):823-7. PubMed ID: 20138296
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled crossover trial with delayed-release cysteamine bitartrate in nephropathic cystinosis: effectiveness on white blood cell cystine levels and comparison of safety.
Langman CB; Greenbaum LA; Sarwal M; Grimm P; Niaudet P; Deschênes G; Cornelissen E; Morin D; Cochat P; Matossian D; Gaillard S; Bagger MJ; Rioux P
Clin J Am Soc Nephrol; 2012 Jul; 7(7):1112-20. PubMed ID: 22554716
[TBL] [Abstract][Full Text] [Related]
8. Cystinosis: a new perspective.
Veys KR; Besouw MT; Pinxten AM; Dyck MV; Casteels I; Levtchenko EN
Acta Clin Belg; 2016 Jun; 71(3):131-7. PubMed ID: 25560059
[TBL] [Abstract][Full Text] [Related]
9. Twice-daily cysteamine bitartrate therapy for children with cystinosis.
Dohil R; Fidler M; Gangoiti JA; Kaskel F; Schneider JA; Barshop BA
J Pediatr; 2010 Jan; 156(1):71-75.e1-3. PubMed ID: 19775699
[TBL] [Abstract][Full Text] [Related]
10. A systematic literature review of cysteamine bitartrate in the treatment of nephropathic cystinosis.
Medic G; van der Weijden M; Karabis A; Hemels M
Curr Med Res Opin; 2017 Nov; 33(11):2065-2076. PubMed ID: 28692321
[TBL] [Abstract][Full Text] [Related]
11. Treatment of cystinosis with delayed-release cysteamine: 6-year follow-up.
Dohil R; Cabrera BL
Pediatr Nephrol; 2013 Mar; 28(3):507-10. PubMed ID: 23001048
[TBL] [Abstract][Full Text] [Related]
12. Switching from immediate- to extended-release cysteamine in nephropathic cystinosis patients: a retrospective real-life single-center study.
Ahlenstiel-Grunow T; Kanzelmeyer NK; Froede K; Kreuzer M; Drube J; Lerch C; Pape L
Pediatr Nephrol; 2017 Jan; 32(1):91-97. PubMed ID: 27350621
[TBL] [Abstract][Full Text] [Related]
13. A Phase 1 Pharmacokinetic Study of Cysteamine Bitartrate Delayed-Release Capsules Following Oral Administration with Orange Juice, Water, or Omeprazole in Cystinosis.
Armas D; Holt RJ; Confer NF; Checani GC; Obaidi M; Xie Y; Brannagan M
Adv Ther; 2018 Feb; 35(2):199-209. PubMed ID: 29411268
[TBL] [Abstract][Full Text] [Related]
14. Long-term clinical benefits of delayed-release cysteamine bitartrate capsules in patients with nephropathic cystinosis (response to "A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis").
Langman CB
Orphanet J Rare Dis; 2023 Jun; 18(1):162. PubMed ID: 37353838
[TBL] [Abstract][Full Text] [Related]
15. Cysteamine bitartrate delayed-release capsules control leukocyte cystine levels and promote statural growth and kidney health in an open-label study of treatment-naïve patients <6 years of age with nephropathic cystinosis.
Vaisbich MH; Caires Ferreira J; Price H; Young KD; Sile S; Checani G; Langman CB
JIMD Rep; 2022 Jan; 63(1):66-79. PubMed ID: 35028272
[TBL] [Abstract][Full Text] [Related]
16. Cystinosis: Therapy adherence and metabolic monitoring in patients treated with immediate-release cysteamine.
Linden S; Klank S; Harms E; Grüneberg M; Park JH; Marquardt T
Mol Genet Metab Rep; 2020 Sep; 24():100620. PubMed ID: 32685378
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients.
Bouazza N; Tréluyer JM; Ottolenghi C; Urien S; Deschenes G; Ricquier D; Niaudet P; Chadefaux-Vekemans B
Orphanet J Rare Dis; 2011 Dec; 6():86. PubMed ID: 22195601
[TBL] [Abstract][Full Text] [Related]
18. The effect of food and liquid pH on the integrity of enteric-coated beads from cysteamine bitartrate delayed-release capsules.
Pavloff N; Hauser TA; Williams C; Isbell SL; Cadieux B; Johnson M
Drug Des Devel Ther; 2018; 12():2795-2804. PubMed ID: 30233142
[TBL] [Abstract][Full Text] [Related]
19. The effects of transitioning from immediate release to extended release cysteamine therapy in Norwegian patients with nephropathic cystinosis: a retrospective study.
Bjerre A; Aase SA; Radtke M; Siva C; Gudmundsdottir H; Forsberg B; Woldseth B; Brackman D
Pediatr Nephrol; 2023 Nov; 38(11):3671-3679. PubMed ID: 37219641
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the treatment of cystinosis.
Schneider JA; Clark KF; Greene AA; Reisch JS; Markello TC; Gahl WA; Thoene JG; Noonan PK; Berry KA
J Inherit Metab Dis; 1995; 18(4):387-97. PubMed ID: 7494398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
